Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
Pulmonary Function Tests01:25

Pulmonary Function Tests

445
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
445
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

415
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
415
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

630
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
630
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of Artificial Intelligence for Predicting Sports Injuries and Customizing Personalized Prevention Strategies: A Scoping Review.

Bioengineering (Basel, Switzerland)·2026
Same author

Toward Precision Cardiac Rehabilitation: Current Limitations and Future Opportunities of Omics and Artificial Intelligence.

Sports medicine (Auckland, N.Z.)·2026
Same author

Sleep under fire: towards a tripartite circadian-neuroendocrine framework for conflict-zone athletes.

British journal of sports medicine·2026
Same author

Fitness under fire: a sports and exercise medicine framework to maintain fitness in the context of modern global conflict, enforced confinement and possible radiation exposure.

British journal of sports medicine·2026
Same author

Directional Asymmetry of Crossover Neuromuscular Fatigue Following Unilateral Handgrip Exercise in Adults and Prepubertal Children.

Medicina (Kaunas, Lithuania)·2026
Same author

Do competitive athletes with cardiovascular diseases need a dedicated sports cardiac rehabilitation clinical pathway? Towards a precision exercise medicine approach.

European journal of preventive cardiology·2026

Related Experiment Video

Updated: Sep 25, 2025

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.9K

Differences in the Spirometry Parameters Between Indigenous and Non-Indigenous Patients with COPD: A Matched Control

Dorothy F L Sze1, Timothy P Howarth2,3, Clair D Lake4

  • 1Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, NT, Australia.

International Journal of Chronic Obstructive Pulmonary Disease
|April 28, 2022
PubMed
Summary

Indigenous patients with chronic obstructive pulmonary disease (COPD) have lower lung function parameters (LFPs) compared to non-Indigenous patients. These differences persist even after matching for key demographic factors, highlighting potential disparities in COPD severity and management.

Keywords:
First NationsGlobal Initiative for Chronic Obstructive Lung DiseaseIndigenouschronic obstructive pulmonary diseaselung function testspirometry

More Related Videos

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.9K
Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
08:44

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

891

Related Experiment Videos

Last Updated: Sep 25, 2025

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.9K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

9.9K
Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
08:44

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

891

Area of Science:

  • Pulmonary Medicine
  • Respiratory Health
  • Indigenous Health

Background:

  • Limited data exists on spirometry parameter comparisons between Indigenous and non-Indigenous patients with chronic obstructive pulmonary disease (COPD).
  • Understanding these differences is crucial for accurate diagnosis and management of COPD in diverse populations.

Purpose of the Study:

  • To compare lung function parameters (LFPs), specifically spirometry values, between Indigenous and non-Indigenous patients diagnosed with COPD.
  • To assess differences in forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and FEV1/FVC ratio, considering age, sex, height, and smoking status.

Main Methods:

  • A retrospective study included Indigenous and non-Indigenous patients diagnosed with COPD between 2012-2020 based on post-bronchodilator (BD) spirometry criteria.
  • Analysis compared spirometry parameters, including lower limit of normal (LLN) values, between the two ethnic groups, with a matched cohort analysis.

Main Results:

  • Indigenous patients with COPD were younger, had a higher proportion of females, were more underweight, and were more likely to be current smokers.
  • Prior to matching, Indigenous patients showed significantly lower percent predicted values for FVC (17%), FEV1 (17%), and FEV1/FVC ratio (-2 points).
  • Even in a matched cohort, Indigenous patients' LFPs remained significantly lower (16% for FVC, 16% for FEV1, and -4 for FEV1/FVC ratio), despite no significant differences in LLN values.

Conclusions:

  • Indigenous Australian patients with COPD exhibit distinct demographic and clinical characteristics compared to non-Indigenous patients.
  • Significantly lower lung function parameters in Indigenous patients suggest potential differences in disease severity, underscoring the need for population-specific reference values.